Epilepsy is a global neurological disorder, but diagnosis, treatment, risk and social consequences are not distributed equally. More than 50 million people worldwide live with epilepsy, and nearly 80% live in low- and middle-income countries. The reasons for unequal outcomes include medicine shortages, poverty, distance from specialist care, preventable causes of brain injury, stigma, limited access to diagnostic testing and differences in health-system capacity.
This collection looks at epilepsy as a global public-health issue. It does not treat one country as the default. Instead, it examines how geography, resources, law, culture and health systems can alter what epilepsy means in everyday life.
Why a global strand matters
The Global Epilepsy Treatment Gap →
Why Epilepsy Care Depends on Where You Live →
What the newest global data show
WHO’s 2025 Global Status Report on Neurology reinforces that access to diagnosis, essential medicines, rehabilitation, specialist care and reliable neurological data remains highly unequal between countries. Epilepsy therefore cannot be described accurately using one health system as the default.
Infrastructure changes clinical outcomes
The same epilepsy syndrome can lead to very different outcomes depending on access to EEG, MRI, antiseizure medicines, emergency treatment, surgery, trained clinicians and continuity of supply.
Global does not mean averaging countries together
Country-specific laws, medicine licences, emergency numbers and service models should remain clearly labelled. Global coverage means explaining both the shared neurological evidence and the health-system differences that shape care.
Epilepsy Care in Indigenous and Remote Communities →
Epilepsy Registries and Surveillance Gaps →
Epilepsy and Disaster Preparedness →
Medication Stock-Outs and Supply-Chain Failure →
Tele-Neurology and Epilepsy Care →
Traditional Healers, Cultural Beliefs and Epilepsy Care →
Cerebral Malaria and Later Epilepsy →
A fact can be medically correct and still give an incomplete picture if it assumes ready access to neurologists, EEG, MRI, surgery or uninterrupted medication. WHO estimates that around three quarters of people with epilepsy in low-income countries do not receive the treatment they need, and in some settings the treatment gap approaches 90%. The global picture therefore includes both neurology and the systems surrounding it.
What this collection covers
- preventable causes of epilepsy worldwide
- neurocysticercosis and epilepsy
- access to antiseizure medicines worldwide
- rural–urban treatment gaps
- poverty and social determinants
- stigma across cultures
- primary-care and task-sharing models
- premature mortality beyond SUDEP
- global access to EEG
- global access to MRI and neuroimaging
- global access to epilepsy surgery
- epilepsy care in humanitarian emergencies and conflict
- migration, displacement and continuity of epilepsy treatment
Core sources
WHO — Epilepsy fact sheet
WHO/ILAE/IBE — Epilepsy: a public health imperative
ILAE Epidemiology Commission — worldwide epilepsy treatment gap
Community voice: Epilesode
Epilesode creates space for people affected by epilepsy to share the parts of life that statistics, classifications and clinical guidance cannot fully capture. Its role here is lived experience and community voice — complementing, not replacing, the medical evidence used across The Untold Side.
Related researched deep dives
- The Global Epilepsy Workforce Gap: Why Specialists Alone Cannot Close It
- Emergency Seizure Care in Resource-Limited Settings
- Epilepsy, Stigma and Discriminatory Law Around the World
- Tele-Neurology and Remote Epilepsy Care
- Building a National Epilepsy Programme
Evidence checked: September 2026.